GGrantIndex
← Leaderboards

Veronica Wendy Setiawan

University Of Southern California

Google Scholar ↗PubMed ↗ORCID ↗
$9,412,373
Attributed
$15,268,233
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY2006–25
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,268,233 · 13

By mechanism

R01$9,190,897 · 4
U01$4,544,010 · 1
K07$632,273 · 1
R03$490,210 · 3
P30$313,833 · 2
U54$65,910 · 1

Top collaborators

Most similar at University Of Southern California

Same institution · by research overlap

Others in their field

Top investigators on “Risk Factors”

Research focus

Risk FactorsMalignant NeoplasmsIncidenceGeneticCohortMortalityResourcesCohort StudiesLife StyleCancer RiskEtiologyAfrican AmericanEpidemiologyObesityWomanHigh RiskRacial And EthnicBasePrevalenceMalignant Neoplasm Of PancreasEthnic GroupCaliforniaDiagnosisCessation Of Life

Grant awards (42)

Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities$844,435
U01 · FY2025 · CA
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis$672,852
R01 · FY2025 · MD · contact PI
Cancer Epidemiology$76,988
P30 · FY2025 · CA · contact PI
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities$466,970
U01 · FY2024 · CA
Cancer Epidemiology$73,302
P30 · FY2024 · CA · contact PI
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities$1,060,827
U01 · FY2023 · CA
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis$615,034
R01 · FY2023 · MD · contact PI
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer$440,314
R01 · FY2023 · CA
Cancer Epidemiology$81,447
P30 · FY2023 · CA · contact PI
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities$1,046,728
U01 · FY2022 · CA
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis$683,885
R01 · FY2022 · MD · contact PI
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer$609,798
R01 · FY2022 · CA
Cancer Epidemiology$82,096
P30 · FY2022 · CA · contact PI
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities$1,125,050
U01 · FY2021 · CA
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis$683,885
R01 · FY2021 · MD
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer$631,044
R01 · FY2021 · CA
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations$350,258
R01 · FY2021 · CA · contact PI
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer$638,665
R01 · FY2020 · CA
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations$382,956
R01 · FY2020 · CA · contact PI
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence$300,442
R01 · FY2020 · CA · contact PI
Contribution of Racial Disparity Towards the Early Development of Pancreatic Cancer$33,457
U54 · FY2020 · CA · contact PI
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer$630,913
R01 · FY2019 · CA
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations$494,016
R01 · FY2019 · CA · contact PI
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence$295,888
R01 · FY2019 · CA · contact PI
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence$188,929
R01 · FY2019 · CA · contact PI
Contribution of Racial Disparity Towards the Early Development of Pancreatic Cancer$32,453
U54 · FY2019 · CA · contact PI
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations$601,819
R01 · FY2018 · CA · contact PI
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence$380,281
R01 · FY2018 · CA · contact PI
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence$194,773
R01 · FY2018 · CA · contact PI
Investigating the cause of racial/ethnic disparity in pancreatic cancer incidence$395,145
R01 · FY2017 · CA · contact PI
Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk$82,438
R03 · FY2015 · CA · contact PI
Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk$82,188
R03 · FY2014 · CA · contact PI
Advances in Endometrial Cancer Epidemiology and Biology$31,100
R13 · FY2014 · CA
Genes, Hormones and Breast Cancer Risk$130,807
K07 · FY2010 · CA · contact PI
Type 1 and Type 2 Endometrial Cancer: Have They Different Risk Factors? A Pooled$81,125
R03 · FY2010 · CA · contact PI
Genes, Hormones and Breast Cancer Risk$131,709
K07 · FY2009 · CA · contact PI
Type 1 and Type 2 Endometrial Cancer: Have They Different Risk Factors? A Pooled$81,500
R03 · FY2009 · CA · contact PI
Genetic Variation in Estrogen Sulfation Genes and Endometrial Cancer Risk$81,459
R03 · FY2009 · CA · contact PI
Genes, Hormones and Breast Cancer Risk$127,910
K07 · FY2008 · CA · contact PI
Genetic Variation in Estrogen Sulfation Genes and Endometrial Cancer Risk$81,500
R03 · FY2008 · CA · contact PI
Genes, Hormones and Breast Cancer Risk$120,295
K07 · FY2007 · CA · contact PI
Genes, Hormones and Breast Cancer Risk$121,552
K07 · FY2006 · CA · contact PI